Molecular basis of the alteration in skin collagen metabolism in response to in vivo dexamethasone treatment: Effects on the synthesis of collagen type I and III, collagenase, and tissue inhibitors of metalloproteinases

British Journal of Dermatology

Volumn 147, Issue 5, 2002, Pages 859-868

  Oishi, Y ^a   Fu, Z W ^a   Ohnuki, Y ^a   Kato, Hisanori ^a   Noguchi, T ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Collagen; Collagenase; Dexamethasone; Lysate RNase protection assay; Tissue inhibitors of metalloproteinases

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGENASE; DEXAMETHASONE; GLUCOCORTICOID; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TROPOCOLLAGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN METABOLISM; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DERMIS; DRUG EFFECT; IMMUNOBLOTTING; MALE; MOLECULAR DYNAMICS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RIBONUCLEASE PROTECTION ASSAY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BODY WEIGHT; COLLAGEN; COLLAGEN TYPE I; COLLAGEN TYPE II; COLLAGENASES; DEXAMETHASONE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; MALE; ORGAN SIZE; RATS; RATS, WISTAR; RNA, MESSENGER; SKIN; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0036436803     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.04949.x     Document Type: Article

References (45)

1. Uitto J, Pulkkinen L, Chu ML. Collagen in biology of extracelluar matrix, blood vessels, and nerves. In: Dermatology in General Medicine (Fitzpatrick TB, Freedberg IM, Eisen AZ et al. eds), 5th edn. New York: McGraw-Hill, 1999; 245-59.
2. 3 human skin collagen, release by pepsin digestion and preponderance in fetal life. J Biol Chem 1974; 249: 3225-31.
3. Cutroneo KR, Rokowski R, Counts DF. Glucocorticoids and collagen synthesis: Comparison of in vivo and cell culture studies. Collagen Rel Res 1981; 1: 557-68.
4. Robey PG. Effect of dexamethasone on collagen metabolism in two strains of mice. Biochem Pharmacol 1979; 28: 2261-6.
5. Shull S, Cutroneo KR. Glucocorticoids change the ratio of type III to type I procollagen extracellularly. Collagen Rel Res 1986; 6: 295-300.
6. Oikarinen A. Dermal connective tissue modulated by pharmacological agents. Int J Dermatol 1992; 31: 149-56.
7. Autio P, Oikarinen A, Melkko J et al. Systemic glucocorticoids decrease the synthesis of type I and type III collagen in human skin in vivo, whereas isotretinoin treatment has little effect. Br J Dermatol 1994; 131: 660-3.
8. Werth VP, Kligman AM, Shi X, Pagnoni A. Lack of correlation of skin thickness with bone density in patients receiving chronic glucocorticoid. Arch Dermatol Res 1998; 290: 388-93.
9. Newman RA, Cutroneo KR. Glucocorticoids selectively decrease the synthesis of hydroxylated collagen peptides. Mol Pharmacol 1978; 14: 185-98.
10. Meisler N, Keefer KA, Ehrlich HP et al. Dexamethasone abrogates the fibrogenic effect of transforming growth factor-β in rat granuloma and granulation tissue fibroblasts. J Invest Dermatol 1997; 108: 285-9.
11. Oikarinen A, Oikarinen H, Tan EML, Uitto J. Modulation of collagen metabolism in cultured human skin fibroblasts by dexa-methasone: Correlation with glucocorticoid receptor density. Acta Derm Venereol (Stockh) 1987; 67: 106-15.
12. Oikarinen A, Vuorio E, Vuorio T. Comparison of the effects of dexamethasone and 13-cis-retinoic acid on connective tissue biosynthesis in human skin fibroblasts. Arch Dermatol Res 1989; 281: 273-8.
13. Mahonen A, Jukkola A, Risteli L et al. Type I procollagen synthesis is regulated by steroids and related hormones in human osteosarcoma cells. J Cell Biochem 1998; 68: 151-63.
14. Shull S, Cutroneo KR. Glucocorticoids coordinately regulate procollagens type I and type III synthesis. J Biol Chem 1983; 258: 3364-9.
15. Raghow R, Gossage D, Knag AH. Pretranslational regulation of type I collagen, fibronectin, and a 50-kilodalton noncollagenous extracellular protein by dexamethasone in rat fibroblasts. J Biol Chem 1986; 261: 4677-84.
16. Delany AM, Jeffrey JJ, Rydziel S, Canalis E. Cortisol increases interstitial collagenase expression in osteoblasts by post-transcriptional mechanisms. J Biol Chem 1995; 270: 26607-12.
17. Sterling KM Jr, Harris MJ, Mitchell JJ et al. Dexamethasone decreases the amounts of type I procollagen mRNAs in vivo and in fibroblast cell cultures. J Biol Chem 1983; 258: 7644-7.
18. Jonat C, Rahmsdorf HJ, Park KK et al. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 1990; 62: 1189-204.
19. Oikarinen A, Haapasaari KM, Sutinen M, Tasanen K. The molecular basis of glucocorticoid-induced skin atrophy: Topical glucocorticoid apparently decreases both collagen synthesis and the corresponding collagen mRNA level in human skin in vivo. Br J Dermatol 1998; 139: 1106-10.
20. Cockayne D, Sterling KM Jr, Shull S et al. Glucocorticoids decrease the synthesis of type I procollagen mRNAs. Biochemistry 1986; 25: 3202-9.
21. Cockayne D, Cutroneo KR. Glucocorticoids coordinate regulation of type I procollagen gene expression and procollagen DNA-binding proteins in chick skin fibroblasts. Biochemistry 1988; 27: 2736-45.
22. Birkedal-Hansen H, Moore WGI, Bodden MKJ et al. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993; 4: 197-250.
23. Knauper V, Lopez-Otin C, Smith B et al. Biochemical characterization of human collagenase-3. J Biol Chem 1996; 271: 1544-50.
24. Koob TJ, Jeffrey JJ, Eisen AZ, Bauer EA. Hormonal interactions in mammalian collagenase regulation. Comparative studies in human skin and rat uterus. Biochim Biophys Acta 1980; 629: 13-23.
25. Brinckerhoff CE, Plucinska IM, Sheldon LA, O'Connor GT. Half-life of synovial cell collagenase mRNA is modulated by phorbol myristate acetate but not by all-trans-retinoic acid or dexamethasone. Biochemistry 1986; 25: 6378-84.
26. König H, Ponta H, Rahmsdorf HJ, Herrlich P. Interference between pathway-specific transcription factors: Glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J 1992; 11: 2241-6.
27. Gomez D, Alonso D, Yoshiji H, Thorgeirsson U. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions. Eur J Cell Biol 1997; 74: 111-22.
28. Slavin J, Unemori E, Hunt TK, Amento E. Transforming growth factor beta (TGF-β) and dexamethasone have direct opposing effects on collagen metabolism in low passage human dermal fibroblasts in vitro. Growth Factors 1994; 11: 205-13.
29. Oishi Y, Fu ZW, Ohnuki Y et al. Effects of protein deprivation on α1(I) and α1(III) collagen and its degrading system in rat skin. Biosci Biotechnol Biochem 2002; 66: 117-26.
30. Niedermuller H, Skalicky M, Hofecker G, Kment A. Investigations on the kinetics of collagen-metabolism in young and old rats. Exp Gerontol 1977; 12: 159-68.
31. Fu Z-W, Kubo T, Sugahara K et al. Cloning of cDNAs encoding quail retinoic acid receptor beta isoforms and changes in their gene expression during gonadotropic growth. Biol Reprod 2001; 64: 231-41.
32. Freinkel RK. Other endocrine diseases. In: Dermatology in General Medicine (Fitzpatrick TB, Freedberg IM, Eisen AZ et al. eds), 5th edn. New York: McGraw-Hill, 1999; 1976-86.
33. Slack JL, Liska DJ, Bornstein P. Regulation of expression of the type I collagen genes. Am J Med Genet 1993; 45: 140-51.
34. Meisler N, Shull S, Xie R et al. Glucocorticoids coordinately regulate type I collagen pro alpha 1 promoter activity through both the glucocorticoid and transforming growth factor beta response elements: A novel mechanism of glucocorticoid regulation of eukaryotic genes. J Cell Biochem 1995; 59: 376-88.
35. Fine A, Poliks CF, Smith BD, Goldstein RH. The accumulation of type I collagen mRNAs in human embryonic lung fibroblasts stimulated by transforming growth factor-beta. Connect Tissue Res 1990; 24: 237-47.
36. Ignotz RA, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261: 4337-45.
37. Parrelli JM, Meisler N, Cutroneo KR. Identification of a gluco-corticoid response element in the human transforming growth factor beta 1 gene promoter. Int J Biochem Cell Biol 1998; 30: 623-7.
38. Shull S, Meisler N, Absher M et al. Glucocorticoid-induced down regulation of transforming growth factor-β1 in adult rat lung fibroblasts. Lung 1995; 173: 71-8.
39. Ghahary A, Shen Q, Shen YJ et al. Induction of transforming growth factor β1 by insulin-like growth factor-1 in dermal fibroblasts. J Cell Physiol 1998; 174: 301-9.
40. Luo J, Reid RE, Murphy LJ. Dexamethasone increases hepatic insulin-like growth factor binding protein-1 (IGFBP-1) mRNA and serum IGFBP-1 concentrations in the rat. Endocrinology 1990; 127: 1456-62.
41. Madlener M. Differential expression of matrix metalloproteinases and their physiological inhibitors in acute murine skin wounds. Arch Dermatol Res 1998; 290: S24-9.
42. Mattila L, Airola K, Ahonen M et al. Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts. J Invest Dermatol 1998; 110: 416-21.
43. Huang HY, Juan YW, Irwin JC et al. Cytokine-mediated regulation of 92-kilodalton type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cells. J Clin Endocrinol Metab 1998; 83: 1721-9.
44. Zhang W, Watson CE, Liu C et al. Glucocorticoids induce a near-total suppression of hyaluronan synthase mRNA in dermal fibroblasts and in osteoblasts: A molecular mechanism contributing to organ atrophy. Biochem J 2000; 340: 91-7.
45. Haake AR, Holbrook K. The structure and development of skin. In: Dermatology in General Medicine (Fitzpatrick TB, Freedberg IM, Eisen AZ et al. eds), 5th edn. New York: McGraw-Hill, 1999; 70-114.